glp-1 drugs news Americans are taking weight-loss in record numbers Medicare is about to cover
Description
Its weight-loss drug indication will be marketed under the brand name Zepbound
Receptor agonists include full agonists, partial agonists, and inverse agonists
All told, the study utilized the medical histories of 2.4 million people
What can GLP-1 and GLP-1RA meds do to help
The primary outcome was the new onset of adverse CVEs, including heart failure, composite incidence of major adverse cardiovascular events (MACE
